<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ClinVarVariationRelease xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://ftp.ncbi.nlm.nih.gov/pub/clinvar/xsd_public/ClinVar_VCV_2.0.xsd" ReleaseDate="2024-05-02">
<VariationArchive RecordType="classified" VariationID="226036" VariationName="NM_003783.3(B3GALT2):c.367T&gt;G (p.Tyr123Asp)" VariationType="single nucleotide variant" Accession="VCV000226036" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2016-05-21" MostRecentSubmission="2016-05-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="227841" VariationID="226036">
      <GeneList>
        <Gene Symbol="B3GALT2" FullName="beta-1,3-galactosyltransferase 2" GeneID="8707" HGNC_ID="HGNC:917" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193178730" stop="193186613" display_start="193178730" display_stop="193186613" Strand="-"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193147859" stop="193155742" display_start="193147859" display_stop="193155742" Strand="-"/>
          </Location>
          <OMIM>603018</OMIM>
        </Gene>
        <Gene Symbol="CDC73" FullName="cell division cycle 73" GeneID="79577" HGNC_ID="HGNC:16783" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193122031" stop="193254815" display_start="193122031" display_stop="193254815" Strand="+"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193091087" stop="193223944" display_start="193091087" display_stop="193223944" Strand="+"/>
          </Location>
          <OMIM>607393</OMIM>
          <Haploinsufficiency last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003783.3(B3GALT2):c.367T&gt;G (p.Tyr123Asp)</Name>
      <CanonicalSPDI>NC_000001.11:193181195:A:C</CanonicalSPDI>
      <VariantType>single nucleotide variant</VariantType>
      <Location>
        <CytogeneticLocation>1q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193181196" stop="193181196" display_start="193181196" display_stop="193181196" variantLength="1" positionVCF="193181196" referenceAlleleVCF="A" alternateAlleleVCF="C"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193150326" stop="193150326" display_start="193150326" display_stop="193150326" variantLength="1" positionVCF="193150326" referenceAlleleVCF="A" alternateAlleleVCF="C"/>
      </Location>
      <ProteinChange>Y123D</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.193150326A&gt;C" Assembly="GRCh37">
            <Expression>NC_000001.10:g.193150326A&gt;C</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.193181196A&gt;C" Assembly="GRCh38">
            <Expression>NC_000001.11:g.193181196A&gt;C</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012691.1" sequenceAccession="NG_012691" sequenceVersion="1" change="g.64239A&gt;C">
            <Expression>NG_012691.1:g.64239A&gt;C</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_052990.1" sequenceAccession="NG_052990" sequenceVersion="1" change="g.10418T&gt;G">
            <Expression>NG_052990.1:g.10418T&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003783.3" sequenceAccession="NM_003783" sequenceVersion="3" change="c.367T&gt;G" MANESelect="true">
            <Expression>NM_003783.3:c.367T&gt;G</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003774.1" sequenceAccession="NP_003774" sequenceVersion="1" change="p.Tyr123Asp">
            <Expression>NP_003774.1:p.Tyr123Asp</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024529.5" sequenceAccession="NM_024529" sequenceVersion="5" change="c.973-22599A&gt;C" MANESelect="true">
            <Expression>NM_024529.5:c.973-22599A&gt;C</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO"/>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_507" sequenceAccession="LRG_507">
            <Expression>LRG_507:g.64239A&gt;C</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA1303641" DB="ClinGen"/>
        <XRef Type="rs" ID="41265203" DB="dbSNP"/>
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00060" Source="1000 Genomes Project"/>
        <AlleleFrequency Value="0.00062" Source="1000 Genomes Project 30x"/>
        <AlleleFrequency Value="0.00192" Source="The Genome Aggregation Database (gnomAD)"/>
        <AlleleFrequency Value="0.00198" Source="Trans-Omics for Precision Medicine (TOPMed)"/>
        <AlleleFrequency Value="0.00231" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server"/>
      </AlleleFrequencyList>
      <GlobalMinorAlleleFrequency Value="0.00060" Source="1000 Genomes Project" MinorAllele="C"/>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003783.3(B3GALT2):c.367T&gt;G (p.Tyr123Asp) AND Hyperparathyroidism 2 with jaw tumors" Accession="RCV000211442" Version="2">
        <ClassifiedConditionList TraitSetID="833">
          <ClassifiedCondition DB="MedGen" ID="C1704981">Hyperparathyroidism 2 with jaw tumors</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-03-11" SubmissionCount="1">Likely benign</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-03-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-05-21" MostRecentSubmission="2016-05-21">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely benign</Description>
        <ConditionList>
          <TraitSet ID="833" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5289" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hyperparathyroidism 2 with jaw tumors</ElementValue>
                <XRef ID="MONDO:0007768" DB="MONDO"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERPARATHYROIDISM, FAMILIAL PRIMARY, WITH MULTIPLE OSSIFYING JAW FIBROMAS</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERPARATHYROIDISM-JAW TUMOR SYNDROME, HEREDITARY</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperparathyroidism 2</ElementValue>
                <XRef ID="Hyperparathyroidism+2/8598" DB="Genetic Alliance"/>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HPT-JT</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM"/>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HRPT2</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM"/>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">CDC73-Related Disorders</Attribute>
                <XRef ID="226120" DB="GeneReviews"/>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of CDC73-related disorders includes the following phenotypes: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Primary hyperparathyroidism, the main finding of HPT-JT syndrome, occurs in up to 95% of affected individuals; onset is typically in late adolescence or early adulthood. HPT-JT-associated primary hyperparathyroidism is usually caused by a single parathyroid adenoma. In approximately 10%-15% of individuals, primary hyperparathyroidism is caused by parathyroid carcinoma. Ossifying fibromas of the mandible or maxilla, also known as cementifying fibromas and cemento-ossifying fibromas, occur in 30%-40% of individuals with HPT-JT syndrome. Although benign, these tumors can be locally aggressive and may continue to enlarge if not treated. Approximately 20% of individuals with HPT-JT syndrome have kidney lesions, most commonly cysts; renal hamartomas and (more rarely) Wilms tumor have also been reported. Benign and malignant uterine tumors appear to be common in women with HPT-JT syndrome. Parathyroid carcinoma. Most parathyroid carcinomas are functional, resulting in hyperparathyroidism and a high serum calcium level; however, nonfunctioning parathyroid carcinomas are also rarely described in individuals with a CDC73-related disorder. A germline CDC73 pathogenic variant has been identified in 20%-29% of individuals with apparently sporadic parathyroid carcinoma. Familial isolated hyperparathyroidism (FIHP). FIHP is characterized by primary hyperparathyroidism without other associated syndromic features. Individuals with CDC73-related FIHP tend to have a more severe clinical presentation and younger age of onset than individuals with FIHP in whom a CDC73 pathogenic variant has not been identified.</Attribute>
                <XRef ID="NBK3789" DB="GeneReviews"/>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10829"/>
                <XRef ID="10829" DB="Office of Rare Diseases"/>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301744</ID>
                <ID Source="BookShelf">NBK3789</ID>
              </Citation>
              <XRef ID="99880" DB="Orphanet"/>
              <XRef ID="C1704981" DB="MedGen"/>
              <XRef ID="MONDO:0007768" DB="MONDO"/>
              <XRef Type="MIM" ID="145001" DB="OMIM"/>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="504204" SubmissionDate="2015-03-11" DateLastUpdated="2016-05-21" DateCreated="2016-05-21">
        <ClinVarSubmissionID localKey="UWMG_6788739|MedGen:C1704981" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000212171" DateUpdated="2016-05-21" DateCreated="2016-05-21" Type="SCV" Version="1" SubmitterName="CSER _CC_NCGL, University of Washington" OrgID="505295" OrganizationCategory="laboratory" OrgAbbreviation="CSER _CC_NCGL"/>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-03-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Amendola et al. (Genome Res. 2015)</Attribute>
          <Citation>
            <ID Source="PubMed">25637381</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">adults with personal and/or family history of colorectal cancer and/or polyps</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="B3GALT2"/>
            <Gene Symbol="CDC73"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_003783.3:c.367T&gt;G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="dbSNP" ID="41265203" Type="rsNumber"/>
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.193150326A&gt;C</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hyperparathyroidism-jaw tumor syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1704981" Type="CUI"/>
          </Trait>
        </TraitSet>
        <StudyName>CSER - NEXT Medicine variant annotation</StudyName>
        <StudyDescription>Diagnostic and incidental finding variants identified by exome sequencing in participants having clinical genetic testing for hereditary colorectal cancer and/or polyps</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>NEXT_V01_2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="504204" TraitType="Disease" MappingType="Name" MappingValue="Hyperparathyroidism-jaw tumor syndrome" MappingRef="Preferred">
        <MedGen CUI="C1704981" Name="Hyperparathyroidism 2 with jaw tumors"/>
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>
</ClinVarVariationRelease>
